0001209191-16-118599.txt : 20160509 0001209191-16-118599.hdr.sgml : 20160509 20160509191414 ACCESSION NUMBER: 0001209191-16-118599 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160505 FILED AS OF DATE: 20160509 DATE AS OF CHANGE: 20160509 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-742-3400 MAIL ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Glasheen James Walter CENTRAL INDEX KEY: 0001532830 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 161633238 MAIL ADDRESS: STREET 1: TECHNOLOGY PARTNERS STREET 2: 100 SHORELINE HWY, SUITE 282-B CITY: MILL VALLEY STATE: CA ZIP: 94941 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-05-05 0 0001479290 Revance Therapeutics, Inc. RVNC 0001532830 Glasheen James Walter C/O TECHNOLOGY PARTNERS 100 SHORELINE HWY, BLDG B, STE 282 MILL VALLEY CA 94941 1 0 0 0 Stock Option (Right to Buy) 16.63 2016-05-05 4 A 0 8000 0.00 A 2026-05-04 Common Stock 8000 8000 D The shares subject to the stock option shall vest on the one year anniversary of May 5, 2016, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) through such vesting date. The stock option represents an annual option grant pursuant to the Issuer's Non-Employee Director Compensation Policy. /s/ Gordon Ho, Attorney-in-Fact 2016-05-09